Expression of IL-8 in Kawasaki disease
- 24 December 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 122 (3) , 514-519
- https://doi.org/10.1046/j.1365-2249.2000.01395.x
Abstract
SUMMARY: We investigated, by Northern blotting, ELISA, and a chemotaxis assay, the expression of IL-8 mRNA, the production of IL-8 protein, and the biological activity of mononuclear cells (MNC), polymorphonuclear neutrophils (PMN) and plasma, respectively, from patients with Kawasaki disease (KD) who received intravenous immunoglobulin (IVIG). IL-8 mRNA expression by MNC and PMN, the level of IL-8 protein, and the neutrophil chemoattractant activity within plasma were all increased in the acute phase of KD, and were significantly elevated following IVIG therapy. The level of chemotactic activity of neutrophils, but not that of monocytes, in response to F-met-leu-phe was decreased in patients with KD after IVIG. The increased expression of IL-8 in PMN and MNC, the increased plasma level of IL-8 and the decreased level of neutrophil chemotactic activity of the patients who received IVIG therapy might inhibit the accumulation of neutrophils at the sites of inflammation, and may thus reduce the risk of aneurysm formation.Keywords
This publication has 25 references indexed in Scilit:
- Update of the Epidemiology of Kawasaki Disease in JapanJournal of Epidemiology, 1996
- Selective induction of interleukin‐1 receptor antagonist and interleukin‐8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin)European Journal of Immunology, 1995
- Human peripheral blood eosinophils produce and release interleukin‐8 on stimulation with calcium ionophoreEuropean Journal of Immunology, 1993
- Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki diseaseThe Journal of Pediatrics, 1992
- Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigrationImmunology Today, 1992
- Value of degenerative change in neutrophils as a diagnostic test for Kawasaki syndromeThe Journal of Pediatrics, 1991
- Endothelial Interleukin-8: A Novel Inhibitor of Leukocyte-Endothelial InteractionsScience, 1989
- Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequenceMolecular Immunology, 1989
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASEThe Lancet, 1984
- Enhanced neutrophilic functions in mucocutaneous lymph node syndrome, with special reference to the possible role of increased oxygen intermediate generation in the pathogenesis of coronary thromboarteritisThe Journal of Pediatrics, 1984